Guo Guangchang: Fosun Emphasizes Strategic Advancement and Exits, Focuses on Core Businesses, and Leverages Operational Capabilities to Participate in Global Markets

HONG KONG,Feb. 25,2025-- On 21 February,Guo Guangchang,Chairman of Fosun International spoke at the 25th Annual Conference of Yabuli China Entrepreneurs Forum 2025,stating that private enterprises are

02-26

"The Future of Travel": Trip.com Group to Showcase Next-Gen Tech at ITB Berlin 2025

Trip.com Group to launch joint Technology Game Changers: Future Trends in Travel & Tourism report at ITB Berlin Press Conference

02-26

ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

6.3% Increase in Full Year 2024 Revenue Compared to Prior Year 13.0% Full Year 2024 Gross Margin Compared to 16.6% in 2023

02-26

India's Bharti Airtel partners Ericsson 5G Core technology to drive 5G evolution

New agreement spans packet core,signaling,charging & policy solutions STOCKHOLM,Feb. 25,2025-- India\'s Bharti Airtel and Ericsson (NASDAQ: ERIC) have strengthened their longstanding partnership t

02-26

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the

02-26

Flexport Unveils 20+ Tech and AI-Powered Products to Modernize Global Supply Chains

At the forefront of the launch are Flexport Intelligence with an AI Insights Builder, and Flexport Control Tower expanding supply chain visibility and management capabilities.

02-26

CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA

Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem

02-26

Baidu Acquires JOYY's Live Streaming Business in China

BEIJING,Feb. 25,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"),a leading AI company with strong Internet foundation,today announced that Baid

02-26

Pudu Robotics Enhances Cleaning Efficiency at Ryugujo Spa Hotel Mikazuki Ryugutei with the Introduction of PUDU SH1

SHENZHEN,China,Feb. 25,2025--Pudu Robotics,a global leader in service robotics,is revolutionizing cleanliness standards at Ryugujo Spa Hotel Mikazuki Ryugutei in Japan,a renowned Japanese hot spring

02-26

MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment

Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned

02-26